gvtcx

Extension Sets

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£60,000,000
Statuscomplete
Category (CPV) 33194000 +2 more
Deadline11 Aug 2022
Procedureopen
OCIDocds-h6vhtk-02eed1

Awards (24)

This procurement was awarded to 24 suppliers. Values shown are per-award; the notice total is £60,000,000.

SupplierValueDateStatus
Baxter Healthcare Limited shared · · active
B. Braun Medical Limited shared · · active
Becton, Dickinson U.K. Limited shared · · active
B M S Critical Care Limited shared · · active
Bunzl Retail & Healthcare Supplies Limited shared · · active
Codan Limited shared · · active
Crest Medical Limited shared · · active
Europlaz Technologies Ltd shared · · active
Fannin (UK) Limited shared · · active
Fresenius Kabi Limited shared · · active
GBUK Ltd shared · · active
ICU UK Medical Limited shared · · active
IMS Euro Limited shared · · active
Infutech Limited shared · · active
Mediplus Limited shared · · active
Merit Medical UK Limited shared · · active
Mornington 2000 LLP shared · · active
Prosum Medical Limited shared · · active
Rocialle Healthcare Limited shared · · active
Smiths Medical International Limited shared · · active
Spirit Medical Limited shared · · active
Vannin Healthcare Global Limited shared · · active
Vygon (U.K.) Limited shared · · active
Westcott Medical Limited shared · · active

description

Extension Sets and Lines are products used to deliver intravenous drugs and fluids to a patient. They can be used either under gravity or more commonly by attachment to a syringe pump. The lines are available in a wide range of specifications and can incorporate features such as filters, anti-siphon valves and anti-reflux valves. These products are used in-conjunction with a number of other products for example intravenous cannulae, intravenous accessories to make up a complete system for the delivery of intravenous therapy.

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £ 10,000,000 to £ 15,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated value over the total Framework Agreement term of 2+2 will be in the region of £60,000,000.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
21 Oct 2021 Prior information notice (F01) Earlier regulations 026468-2021
11 Jul 2022 Contract notice (F02) Earlier regulations 018859-2022
2 Aug 2022 Corrigendum (F14) Earlier regulations 021152-2022
16 Feb 2023 Contract award notice (F03) Earlier regulations 004780-2023

more from NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.